Search Results - Hennan, Jim

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    WED-196 Analyses of fibrosis biomarkers PRO-C3 and ELF in resmetirom treated patients from MAESTRO-NASH, a 52 Week NASH/MASH serial liver biopsy study

    WED-196 Analyses of fibrosis biomarkers PRO-C3 and ELF in resmetirom treated patients from MAESTRO-NASH, a 52 Week NASH/MASH serial liver biopsy study by Anstee, Quentin M., Schattenberg, Jörn M, Taub, Rebecca, Labriola, Dominic, Zhang, Hang, Hennan, Jim

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Utility of FIB-4 thresholds to identify patients with at-risk F2-F3 NASH based on screening data from a 2000 patient biopsy confirmed cohort of resmetirom Phase 3 clinical trial, MAESTRO-NASH

    Utility of FIB-4 thresholds to identify patients with at-risk F2-F3 NASH based on screening data from a 2000 patient biopsy confirmed cohort of resmetirom Phase 3 clinical trial, M... by Schattenberg, Jörn, Alkhouri, Naim, Taub, Rebecca, Hennan, Jim, Noureddin, Mazen, Harrison, Stephen

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Retrospective AI-based measurement of NASH histology (AIM-NASH) analysis of biopsies from Phase 2 study of Resmetirom confirms significant treatment-induced changes in histologic features of non-alcoholic steatohepatitis

    Retrospective AI-based measurement of NASH histology (AIM-NASH) analysis of biopsies from Phase 2 study of Resmetirom confirms significant treatment-induced changes in histologic f... by Harrison, Stephen, Iyer, Janani, Biddle-Snead, Charles, Hoffman, Sara, Le, Quang, Mountain, Victoria, Resnick, Murray, Wack, Katy, Hennan, Jim, Taub, Rebecca

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Characterizing the histologic implications of resmetirom-induced liver volume reduction using artificial intelligence-powered digital pathology

    Characterizing the histologic implications of resmetirom-induced liver volume reduction using artificial intelligence-powered digital pathology by Mistry, Pratik, Stanford-Moore, Adam, Egger, Robert, Glickman, Jonathan, Baker, Brian, Chandra, Nidhi, Juyal, Dinkar, Khosla, Archit, Drage, Michael, Resnick, Murray, Wack, Katy, Hennan, Jim, Loomba, Rohit, Harrison, Stephen, Taub, Rebecca, Iyer, Janani

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    WED-522 - Characterizing the histologic implications of resmetirom-induced liver volume reduction using artificial intelligence-powered digital pathology

    WED-522 - Characterizing the histologic implications of resmetirom-induced liver volume reduction using artificial intelligence-powered digital pathology by Mistry, Pratik, Stanford-Moore, Adam, Egger, Robert, Glickman, Jonathan, Baker, Brian, Chandra, Nidhi, Juyal, Dinkar, Khosla, Archit, Drage, Michael, Resnick, Murray, Wack, Katy, Hennan, Jim, Loomba, Rohit, Harrison, Stephen, Taub, Rebecca, Iyer, Janani

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: